Please login to the form below

Not currently logged in
Email:
Password:

Chiltern promotes Aize Smink and Linda Christmas

CRO makes changes as new CEO Dr Jim Esinhart takes office

Chiltern chief operating officer Aize SminkUK-based CRO Chiltern has made two senior appointments, promoting Aize Smink to chief operating officer and Linda Christmas to chief resourcing officer.

Smink was formerly senior executive VP of global clinical development and in his new role working out of Brussels will provide leadership and oversight of Chiltern's global clinical development and global scientific services divisions.

He has more than 20 years of development experience, spanning pharma, biotech and medical devices, and has been with Chiltern since 2006.

Meanwhile, Linda Christmas steps up from senior executive VP of global resourcing solutions in a promotion that Chiltern said recognises the role she has played as the head of its global resourcing division.

She has been with Chiltern since 1997 and has more than 25 years of clinical research experience.

The company makes the executive changes as its new CEO Dr Jim Esinhart takes office.

Commenting on the two promotions he said: “Aize and Linda are talented and experienced industry leaders. These appointments build on their strengths, as well as the strengths of our global team.

“As a leading mid-tier CRO, we believe the integration of services, technology and optimal resourcing are critical for success. I look forward to working closely with Aize and Linda in their new roles as we continue Chiltern's long-standing track record of delivering high quality and responsive services.”

6th November 2012

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics